IDEXX Laboratories Announces New Testing Capabilities for the IDEXX SNAPshot Dx® Analyzer [Trade]
IDEXX introduced the SNAP® rapid assay test with its unique and highly accurate ELISA technology in a test kit over 17 years ago. The tests were visually read by veterinary professionals with the results recorded or keyed in by hand. SNAP® technology became and continues to be the gold standard in point-of-care testing. With the introduction of this new capability on the SNAPshot Dx analyzer, practices now have the option to "œsnap" the SNAP FIV/FeLV Combo Test or the SNAP cPL test, load the test into the analyzer and the instrument takes care of the rest: timing the assay, interpreting the result, and adding to the patient record in the IDEXX VetLab® Station. This frees staff to move onto other practice needs.
"Busy practices are always looking for ways to create efficiencies and streamline work flow," said Mike Sullivan, Marketing Director for the IDEXX SNAP test line. "The ability to snap the test kit, load the SNAPshot Dx® analyzer and go, gives practices a new opportunity to begin to automatically integrate their qualitative diagnostic results seamlessly into the electronic medical record, and free up more time to manage the patient."
In addition, with this new SNAP® qualitative assay capability, the SNAPshot Dx analyzer can help to standardize practice protocols, create more efficient work flow by running multiple patients simultaneously and significantly reduce costly missed charges. Users simply insert activated SNAP® ELISA tests into either of two ports. The SNAPshot Dx analyzer reads the assay results at the right time and, through the IDEXX VetLab Station, automatically downloads the data into the patient record. Results are then incorporated into the IDEXX VetLab Station's easy-to-read integrated diagnostic report for a complete picture of patient health.
For more information about the IDEXX SNAPshot Dx® Analyzer and the entire line of SNAP® tests, please call IDEXX at 1-800-248-2483 (option 1) or visit www.idexx.com/snapshotdx.
About the IDEXX VetLab® Suite
The IDEXX VetLab® Suite is a highly integrated set of veterinary analyzers that provides fast and flexible results on a patient’s blood and urine within minutes of the pet visit. Diagnostic capabilities include clinical chemistry, electrolytes, hematology with five-part differential and reticulocytes, endocrinology, blood gases, coagulation, urinalysis and infectious diseases. The IDEXX VetLab® Station, which serves as an information system for the in-house laboratory, uses the power of SmartLink™ technology to integrate results from all the analyzers—including the new Catalyst Dx™ and SNAPshot Dx® analyzers—and IDEXX SNAP® point-of-care tests into a single comprehensive and easy-to-use patient report and stores this information in its database for easy future reference and historical results-trending capability. And now IDEXX SmartService™ Solutions utilizes the Internet to deliver proactive service and support for most IDEXX VetLab® instruments.*
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, to improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,500 people and offers products to customers in over 100 countries.
Note Regarding Forward-Looking Statements
This press release contains statements about the Company's business prospects for future periods that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's expectations of future events as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Actual results could differ materially from management's expectations. Factors that could cause or contribute to such differences include the Company's ability to develop, manufacture, introduce and market new products and enhancements to existing products. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2007 (PDF, 1.5 MB) and on the Quarterly Report on Form 10-Q for the quarter ended September 30, 2008 (PDF, 390 KB), in the section captioned "Risk Factors."
Contact: Mike Sullivan, Marketing Director, 1-207-556-4632, michael-sullivan@idexx.com